Copyright © 2012 Jens Garbade et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The third generation of left ventricular assist devices (LVADs) has been shown to improve outcome and quality of life in patients suffering from acute and chronic heart failure. However, VAD-associated complications are still a challenge in the clinical practice. Here we report the resolution of a mobile thrombus formation in the proximity of the inflow cannula of a third generation of LVADs (HVAD Pump, HeartWare, Inc.) in a patient with chronic heart failure 4 months after implantation. 1
Pump thrombosis is a devastating complication after left ventricular assist device implantation. Thi...
Despite advances in technology, ventricular assist devices still experience a number of complication...
Includes bibliographical references (pages 75-80).Heart transplantation remains the primary treatmen...
The third generation of left ventricular assist devices (LVADs) has been shown to improve outcome an...
Mechanical circulatory support (MCS) devices, such as left ventricular assist devices (LVADs) are ve...
AbstractHeart failure is one of the leading causes of mortality and morbidity in the world. Heart tr...
AbstractThe left ventricular assist device (LVAD) is a battery-operated, mechanical pump-type device...
The use of left ventricular assist devices (LVADs) in themanagement of advanced heart failure has gr...
Left ventricular assist devices (LVADs), more importantly the continuous-flow subclass, have revolut...
Pump thrombosis is a serious complication of continuous-flow left ventricular assist devices (LVAD)....
The Jarvik 2000 Flowmaker® is an implantable left-ventricular assist device (LVAD) that produces axi...
The use of a left ventricular assist device has increased and is a primary surgical treatment for he...
Background: Pump thrombosis (PT) is a dreaded complication after left ventricular assist device (LVA...
\(\bf Background/Aims:\) Long-term mechanical assist devices are now commonly used in the treatment ...
PubMed ID: 23622612Background: In this report, we share our experience with left ventricular assist ...
Pump thrombosis is a devastating complication after left ventricular assist device implantation. Thi...
Despite advances in technology, ventricular assist devices still experience a number of complication...
Includes bibliographical references (pages 75-80).Heart transplantation remains the primary treatmen...
The third generation of left ventricular assist devices (LVADs) has been shown to improve outcome an...
Mechanical circulatory support (MCS) devices, such as left ventricular assist devices (LVADs) are ve...
AbstractHeart failure is one of the leading causes of mortality and morbidity in the world. Heart tr...
AbstractThe left ventricular assist device (LVAD) is a battery-operated, mechanical pump-type device...
The use of left ventricular assist devices (LVADs) in themanagement of advanced heart failure has gr...
Left ventricular assist devices (LVADs), more importantly the continuous-flow subclass, have revolut...
Pump thrombosis is a serious complication of continuous-flow left ventricular assist devices (LVAD)....
The Jarvik 2000 Flowmaker® is an implantable left-ventricular assist device (LVAD) that produces axi...
The use of a left ventricular assist device has increased and is a primary surgical treatment for he...
Background: Pump thrombosis (PT) is a dreaded complication after left ventricular assist device (LVA...
\(\bf Background/Aims:\) Long-term mechanical assist devices are now commonly used in the treatment ...
PubMed ID: 23622612Background: In this report, we share our experience with left ventricular assist ...
Pump thrombosis is a devastating complication after left ventricular assist device implantation. Thi...
Despite advances in technology, ventricular assist devices still experience a number of complication...
Includes bibliographical references (pages 75-80).Heart transplantation remains the primary treatmen...